ANDA 205269, held by Hisun Pharm Hangzhou. Donepezil Hydrochloride.
As of Nov 16, 2026, ANDA 205269 (Donepezil Hydrochloride), held by Hisun Pharm Hangzhou, was first approved by FDA on Jul 27, 2018, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 27, 2018 | Original application | Approved | None posted |
| Donepezil Hydrochloride5MG · tablet, orally disintegrating;oral | Donepezil Hydrochloride | Rx |
| Donepezil Hydrochloride10MG · tablet, orally disintegrating;oral | Donepezil Hydrochloride | Rx |
| Dec 30, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jul 27, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters